APPLICATION
ANDA065010
TYPE
ANDA
ORIGINAL APPROVAL
2002-05-23
LATEST ACTION
2012-01-17
ROUTE
ORAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Discontinued
Products
NEO-FRADINDiscontinued
NEOMYCIN SULFATE EQ 87.5MG BASE/5ML · SOLUTION · ORAL
Approval history
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.